Categories: News

Paris-Saclay SPRING is back, with a focus on deep tech.

For its 4th edition, the conference will bring together major players, startups and academics to focus on the latest innovation in the strengths of the cluster: deep tech, energy transition, mobility, foodtech, healthtech… and their many applications for the future of each industry – or the planet.

NEW YORK and PARIS, April 19, 2022 /PRNewswire/ — Paris-Saclay SPRING returns on May 12 & 13, 2022, in a hybrid format: both online and at the Ecole Polytechnique on the Paris-Saclay Campus. Paris-Saclay SPRING will bring together the best of French innovation in five strategic sectors: FoodTech, Mobility, Digital Technologies, GreenTech, and Health-Biotech.

Over the past 4 years, Paris-Saclay SPRING has become one of the leading industrial and sustainable innovation events in Europe. Over two days, it provides direct access to 15% of French research, as well as researchers from Paris-Saclay University, Institut Polytechnique de Paris, and renowned schools. It also allows connections with R&D and industrial leaders from 150 international groups and 500 French Tech startup members.

Philippe Van de Maele, CEO Paris-Saclay development authority: “Within the past few years, both SPRING and Paris-Saclay itself have grown beyond our greatest expectations: IBM set up their AI research center on our campus at the end of last year, and Intel just announced that they would also open their own research center. They will join French startups that already have a foot in the US: Ivalua and WinMs who both already opened their American subsidiaries, and Ynsect, made famous by Robert Downey Jr last year, and who just acquired US-based Jord”

In a nutshell, Paris-Saclay SPRING is:

  • 7 hours of debates and live conferences
  • 50 startups selected in the SPRING 50 contest
  • 100 exhibitors
  • Innovation tours in laboratories and private R&D centers open on this unique occasion. 

Complete program and registration available online.

Follow the event live online or with replays, available May 16 on the event website.

Press contacts:

EPA Paris-Saclay / Gaëlle Coutant
gaelle.coutant@oin-paris-saclay.fr – +33 1 64 5436 67

About Paris-Saclay

Paris-Saclay comprises 40% of Paris Region public research and 40% of industrial high-tech R&D*. Major groups including Danone, Thales, EDF, Safran, PSA, Renault, Airbus Group, Air Liquide, GE and Nokia are collaborating and cross-fertilizing with a large number of innovative SMEs and start-ups in the area, making the cluster uniquely equipped to adapt to the innovation models of the 21st century.

Logo – https://healthtechnologynet.com/wp-content/uploads/2022/04/Paris_Saclay_SPRING_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/paris-saclay-spring-is-back-with-a-focus-on-deep-tech-301528255.html

SOURCE Paris-Saclay; Business France

Staff

Recent Posts

Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025

If you are male and in your 40's and 50's and feel your testosterone levels…

11 hours ago

The Anxiety Clinic Launches Innovative Approach to Transform Anxiety into Positive Energy

Transforming Anxiety into Positive Energy: A New Approach by The Anxiety ClinicBondi Junction, New South…

15 hours ago

Solace Psychology Announces Expanded Holiday Stress Management and Mental Health Support Services

Embracing Mental Well-Being During the Festive SeasonCarlton North, Australia--(Newsfile Corp. - December 24, 2024) -…

17 hours ago

Strong Natural Diet Pill Over the Counter for 2025 – PhenQ OTC Weight Loss Supplement

If you are researching the strongest over the counter weight loss supplements in 2025 -…

17 hours ago

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

19 hours ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

20 hours ago